Putting the Brake on Inflammatory Responses: The Role of Glucocorticoids

IUBMB Life

Volumn 55, Issue 9, 2003, Pages 497-504

  Hermoso, Marcela A ^a   Cidlowski, John A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Activator protein 1 (AP 1); Glucocorticoid receptor (GR); Glucocorticoids (GC); Nuclear factor B (NF B); Toll like receptors (TLRs)

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

CELL INTERACTION; CYTOKINE PRODUCTION; DNA BINDING; DRUG MECHANISM; DRUG PROTEIN BINDING; GENE REPRESSION; HUMAN; INFLAMMATION; INHIBITION KINETICS; MOLECULAR DYNAMICS; NONHUMAN; PHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY DISTRESS; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

ANIMALS; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; NF-KAPPA B; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EID: 0344012614     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540310001642072     Document Type: Review

References (59)

1. Abbas, A. K., Murphy, K. M., and Sher, A. (1996) Functional diversity of helper T lymphocytes. Nature 383(6603), 787-793.
2. Jochum, W., Passegue, E., and Wagner, E, F. (2001) AP-1 in mouse development and tumorigenesis. Oncogene 20(19) 2401-2412.
3. Shaulian, E., and Karin, M. (2001 AP-1 in cell proliferation and survival. Oncogene 20(19), 2390-2400.
4. Dhanasekaran, N., and Premkumar Reddy, E. (1998) Signaling by dual specificity kinases. Oncogene 17(11 Reviews), 1447-1455.
5. Whitmarsh, A. J., and Davis, R. J. (1966) Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74(10), 589-607.
6. Chen, R. H., Juo, P. C., Curran, T., and Blenis, J. (1996) Phosphorylation of c-Fos at the C-terminus enhances its transforming activity. Oncogene 12(7), 1493-1502.
7. Skinner, M., Qu, S., Moore, C., and Wisdom, R. (1997) Transcriptional activation and transformation by FosB protein require phosphorylation of the carboxyl-terminal activation domain. Mol. Cell. Biol. 17(5), 2372-2380.
8. Gruda, M., C., Kovary, K., Metz, R., and Bravo, R. (1994) Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene 9(9), 2537-2547.
9. Angel, P., and Karin, M. (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1072(2-3), 129-157.
10. Baldwin, A. S., Jr. (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683.
11. Yang, R. B., Mark, M. R., Gray, A., Huang, A., Xie, M. H., Zhang, M., Goddard, A., Wood, W. I., Gurney, A. L., and Godowski, P. J. (1998) Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395(6699), 284-288.
12. Ghosh, S., May, M. J., and Kopp, E. B. (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
13. Xiao, G., Harhaj, E. W., and Sun, S. C. (2001) NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p 100. Mol. Cell 7(2), 401-409.
14. Zhong, H., Voll, R. E., and Ghosh, S. (1998) Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1(5), 661-671.
15. Karin, M., and Ben-Neriah, Y. (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18, 621-663.
16. Arenzana-Seisdedos, F., Thompson, J., Rodriguez, M. S., Bachelerie, F., Thomas, D., and Hay, R. T. (1995) Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B. Mol. Cell. Biol. 15(5), 2689-2696.
17. Whiteside, S. T., Epinat, J. C., Rice, N. R., and Israel, A. (1997) I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. EMBO J. 16(6), 1413-1426.
18. Ghosh, S., and Karin, M. (2002) Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl), S81-S96.
19. Mosialos, G., and Gilmore, T. D. (1993) v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence. Oncogene 8(3), 721-730.
20. Neumann, M., Grieshammer, T., Chuvpilo, S., Kneitz, B., Lohoff, M., Schimpl, A., Franza, B. R. Jr., and Serfling, E. (1995) RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J. 14(9), 1991-2004.
21. Leitges, M., et al. (2001) Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. Mol. Cell 8(4), 771-780.
22. Bonnard, M., Mirtsos, C., Suzuki, S., Graham, K., Huang, J., Ng, M., Itie, A., Wakeham, A., Shahinian, A., Henzel, W. J., Elia, A. J., Shillinglaw, W., Mak, T. W., Cao, Z., and Yeh, W. C. (2000) Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J. 19(18), 4976-4985.
23. Wang, D., Westerheide. S. D., Hanson, J. L., and Baldwin, A. S., Jr. (2000) Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J. Biol. Chem. 275(42), 32592-32597.
24. Eder, J. (1997) Tumour necrosis factor alpha and interleukin 1 signalling: do MAPKK kinases connect it all? Trends Pharmacol. Sci. 18(9), 319-322.
25. Hollenberg, S. M., and Evans, R. M. (1988) Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 55(5), 899-906.
26. Dittmar, K. D., Demady, D. R., Stancato, L. F., Krishna, P., and Pratt, W. B. (1997) Folding of the glucocorticoid receptor by the heat shock protein (hsp) 90-based chaperone machinery. The role of p23 is to stabilize receptor.hsp90 heterocomplexes formed by hsp90.p60.hsp70. J. Biol. Chem. 272(34), 21213-21220.
27. Dittmar, K. D., Banach, M., Galigniana, M. D., and Pratt, W. B. (1998) The role of DnaJ-like proteins in glucocorticoid receptor.hsp90 heterocomplex assembly by the reconstituted hsp90.p60.hsp70 foldosome complex. J. Biol. Chem. 273(13), 7358-7366.
28. Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Thompson, E. B., Rosenfeld, M. G., and Evans, R. M. (1985) Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318(6047), 635-641.
29. Oakley, R. H., Sar, M., and Cidlowski, J. A. (1996) The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J. Biol. Chem. 271(16), 9550-9559.
30. Cole, T. J., et al. (1995) Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 9(13), 1608-1621.
31. Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., and Karin, M. (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270(5234), 286-290.
32. Drouin, J., Sun, Y. L., Chamberland, M., Gauthier, Y., De Lean, A., Nemer, M., and Schmidt, T. J. (1993) Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J. 12(1), 145-156.
33. Sakai, D. D., Helms, S., Carlstedt-Duke, J., Gustafsson, J. A., Rottman, F. M., and Yamamoto, K. R. (1988) Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev. 2(9), 1144-1154.
34. Webster, J. C., and Cidlowski, J. A. (1999) Mechanisms of Glucocorticoid-receptor-mediated Repression of Gene Expression. Trends Endocrinol. Metab. 10(10), 396-402.
35. Schule, R., Rangarajan, P., Kliewer, S., Ransone, L. J., Bolado, J., Yang, N., Verma, I. M., and Evans, R. M. (1990) Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62(6), 1217-1226.
36. Almawi, W. Y., Lipman, M. L., Stevens, A. C., Zanker, B., Hadro, E. T., and Strom, T. B. (1991) Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma. J. Immunol. 146(10), 3523-3527.
37. Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., and Schutz, G. (1998) DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93(4), 531-541.
38. Bodwell, J. E., Webster, J. C., Jewell, C. M., Cidlowski, J. A., Hu, J. M., and Munck, A. (1998) Glucocorticoid receptor phosphorylation: overview, function and cell cycle-dependence. J. Steroid Biochem. Mol. Biol. 65(1-6), 91-99.
39. McKenna, N. J., Lanz, R. B., and O'Malley, B. W. (1999) Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20(3), 321-344.
40. Wyszomierski, S. L., Yeh, J., and Rosen, J. M. (1999) Glucocorticoid receptor/signal transducer and activator of transcription 5 (STAT5) interactions enhance STAT5 activation by prolonging STAT5 DNA binding and tyrosine phosphorylation. Mol. Endocrinol. 13(2), 330-343.
41. Jackson, T. A., Richer, J. K., Bain, D. L., Takimoto, G. S., Tung, L., and Horwitz, K. B. (1997) The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol. Endocrinol. 11(6), 693-705.
42. Da Silva, J. A. (1999) Sex hormones and glucocorticoids: interactions with the immune system. Ann. N. Y. Acad. Sci. 876, 102-117; discussion 117-118.
43. Meduri, G. U., Tolley, E. A., Chrousos, G. P., and Stentz, F. (2002) Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am. J. Respir. Crit. Care Med. 165(7), 983-991.
44. Wissink, S., van Heerde, E. C., vand der Burg, B., and van der Saag, P. T. (1998) A dual mechanism mediates repression of NF-kappaB activity by glucocorticoids. Mol. Endocrinol. 12(3), 355-363.
45. Brostjan, C., Anrather, J., Csizmadia, V., Natarajan, G., and Winkler, H. (1997) Glucocorticoids inhibit E-selectin expression by targeting NF-kappaB and not ATF/c-Jun. J. Immunol. 158(8), 3836-3844.
46. Heck, S., Kullmann, M., Gast, A., Ponta, H., Rahmsdorf, H. J., Herrlich, P., and Cato, A. C. (1994) A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J. 13(17), 4087-4095.
47. McKay, L. I., and Cidlowski, J. A. (1998) Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol. Endocrinol. 12(1), 45-56.
48. Scheimnan, R. I., Cogswell, P. C., Lofquist, A. K., and Baldwin A. S. Jr. (1995) Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270(5234), 283-286.
49. McKay, L. I., and Cidlowski, J. A. (1999) Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr. Rev. 20(4), 435-459.
50. Nissen, R. M., and Yamamoto, K. R. (2000) The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 14(18), 2314-2329.
51. Bannister, A. J., and Kouzarides, T. (1996) The CBP co-activator is a histone acetyltransferase. Nature 384(6610), 641-643.
52. Freedman, L. P. (1999) Increasing the complexity of coactivation in nuclear receptor signaling. Cell 97(1), 5-8.
53. De Bosscher, K., Vanden Berghe, W., Vermeulen, L., Plaisance, S., Boone, E., and Haegeman, G. (2000) Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc. Natl. Acad. Sci. USA 97(8), 3919-3924.
54. McKay, L. I., and Cidlowski, J. A. (2000) CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism. Mol. Endocrinol. 14(8), 1222-1234.
55. Stocklin, E., Wissler, M., Gouilleux, F., and Groner, B. (1996) Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383(6602), 726-728.
56. Shuto, T., Imasato, A., Jono, H., Sakai, A., Xu, H. Watanabe, T., Rixter, D. D., Kai, H., Andalibi, A., Linthicum, F., Guan, Y. L., Han, J., Cato, A. C., Lim, D. J., Akira, S., and Li, J. D. (2002) Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J. Biol. Chem. 277(19), 17263-17270.
57. Chang, L., and Karin, M. (2001) Mammalian MAP kinase signalling cascades. Nature 410(6824), 37-40.
58. Lasa, M., Abraham, S. M., Boucheron, C., Saklatvala, J., and Clark, A. R. (2002) Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol. Cell. Biol. 22(22), 7802-7811.
59. Webster, J. C., Oakley, R. H., Jewell, C. M., and Cidlowski, J. A. (2001) Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc. Natl. Acad. Sci. USA 98(12), 6865-6870.